Post-earnings recap
Reported
Tue, Aug 3, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health's significant EPS miss has led to a notable decline in stock price, dropping 10.83%. The lack of revenue data and guidance further adds to uncertainty around the company's financial outlook. Investors may be concerned about the company's ability to meet future expectations without clear direction from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.66 | N/A | -270.78% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.